Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)

Patricia Johansson, Ludger Klein-Hitpass, René Scholtysik, Marc Seifert, Ulrich Jäger, Gertraud Tschurtschenthaler, Ulrich Dührsen, Ralf Küppers, Jan Dürig

Blood (2012) 120 (21): 3512.

https://doi.org/10.1182/blood.V120.21.3512.3512

Published: 2012

Journal Articles

Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic Leukemia

Maria Göbel, Michael Möllmann, Andre Görgens, Ulrich Dührsen, Andreas Hüttmann, Bernd Giebel, Anke Unger, Axel Choidas, Jan Dürig

Blood (2012) 120 (21): 1799.

https://doi.org/10.1182/blood.V120.21.1799.1799

Published: 2012

Journal Articles

Protein Kinase C-β Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo

Gloria Lutzny, Thomas Kocher, MSc, Martina Rudelius, Marc Schmidt-Supprian, Ludger Klein-Hitpass, Jan Dürig, Robert A.J. Oostendorp, PhD, Christian Peschel, MD, Alexander Egle, Ingo Ringshausen

Blood (2012) 120 (21): 314.

https://doi.org/10.1182/blood.V120.21.314.314

Published: 2012

Journal Articles

Potent Anti-Leukemic Activity of a Novel Cdk9 Inhibitor in Preclinical CLL Mouse Models

Joachim Rudolf Göthert, MD, Roze Imsak, Michael Möllmann, Stefanie Weber, Mandy Necke, Ulrich Dührsen, MD, Jan Eickhoff, Matthias Baumann, Anke Unger, Carsten Schultz-Fademrecht, Jan Dürig, MD

Blood (2011) 118 (21): 1789.

https://doi.org/10.1182/blood.V118.21.1789.1789

Published: 2011

Journal Articles

Correlations Between Ofatumumab Exposure and Treatment Outcomes for Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Ofatumumab, Fludarabine, and Cyclophosphamide Chemoimmunotherapy

William G. Wierda, MD, PhD, Roxanne C. Jewell, PhD, Thomas J. Kipps, M.D., Ph.D, Jan Dürig, MD, Laimonas Griskevicius, Stephan Stilgenbauer, MD, Lukas Smolej, M.D., Ph.D., Georg Hess, Francisco J. Hernandez-Ilizaliturri, MD, Swaminathan Padmanabhan, MBBS, MD, Lei Fang, Michele M. Gorczyca, MS, Geoffrey W. Chan, MD, Ira V. Gupta, MD, Steen Lisby

Blood (2011) 118 (21): 1793.

https://doi.org/10.1182/blood.V118.21.1793.1793

Published: 2011

Journal Articles

Expanded CLL CD8 + T-Cells Are Driven Into a Senescent KLRG1 + Effector Memory Phenotype

Joachim Rudolf Göthert, MD, Lewin Eisele, MD, Ludger Klein-Hitpass, Stefanie Weber, Anja Führer, Ludger Sellmann, MD, Alexander Roeth, MD, Ulrich Duehrsen, MD, Hanspeter Pircher, Jan Dürig

Blood (2010) 116 (21): 913.

https://doi.org/10.1182/blood.V116.21.913.913

Published: 2010

Journal Articles

Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany

Lewin Eisele, Jan Dürig, Andreas Huttmann, Ulrich Dührsen, Anja Führer, Sabrina Kieruzel, Roland Assert, Beate Bokhof, Raimund Erbel, Klaus Mann, Karl-Heinz Jöckel, Susanne Moebus

Blood (2010) 116 (21): 4037.

https://doi.org/10.1182/blood.V116.21.4037.4037

Published: 2010

Journal Articles

Polyclonal Free Light Chain Elevation and Mortality In the German Heinz Nixdorf Recall Study

Lewin Eisele, Jan Dürig, Andreas Huttmann, Ulrich Dührsen, Anja Führer, Sabrina Kieruzel, Martina Bröcker-Preuss, Beate Bokhof, Raimund Erbel, Klaus Mann, Karl-Heinz Jöckel, Susanne Moebus

Blood (2010) 116 (21): 3903.

https://doi.org/10.1182/blood.V116.21.3903.3903

Published: 2010

Journal Articles

Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial.

William G Wierda, Thomas J Kipps, Jan Dürig, Laimonas Griskevicius, Stephan Stilgenbauer, Jiri Mayer, Lukas Smolej, Georg Hess, Rasa Griniute, Francisco J Hernandez-Ilizaliturri, Swaminathan Padmanabhan, Michele Gorczyca, Geoffrey Chan, Ira Gupta, Marc Andersen, Claus Strange, Tina G Nielsen, Charlotte A Russell

Blood (2009) 114 (22): 207.

https://doi.org/10.1182/blood.V114.22.207.207

Published: 2009

Journal Articles

Mir-34a as Part of the Chemotherapy Resistance Network in Chronic Lymphocytic Leukemia.

Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P Kater, Andreas Bühler, Dirk Winkler, Dirk Kienle, Jan Dürig, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer

Blood (2008) 112 (11): 1209.

https://doi.org/10.1182/blood.V112.11.1209.1209

Published: 2008

Journal Articles

Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status.

Jan Dürig, MD, Andreas Hüttmann, MD, Ludger Klein-Hitpass, PhD, Ludger Sellmann, MD, Ulrich Dührsen, MD

Blood (2006) 108 (11): 4954.

https://doi.org/10.1182/blood.V108.11.4954.4954

Published: 2006

Journal Articles

The Gene Expression Profile of T-Cell Prolymphocytic Leukemia with inv(14)(q11q32) Reflects the Pattern of Chromosomal Imbalances.

Jan Dürig, MD, Stefanie Bug, MSc, Ludger Klein-Hitpass, PhD, Tanja Boes, PhD, Thomas Jöns, PhD, Ulrich Dührsen, MD, Reiner Siebert, MD

Blood (2006) 108 (11): 2290.

https://doi.org/10.1182/blood.V108.11.2290.2290

Published: 2006

Journal Articles

Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

Holger Nückel, Ulrich H. Frey, Maja Bau, Ludger Sellmann, Jens Stanelle, Jan Dürig, Karl-Heinz Jöckel, Ulrich Dührsen, Winfried Siffert

Blood (2006) 109 (1): 290–297.

https://doi.org/10.1182/blood-2006-03-007567

Published: 2006

Journal Articles

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

Holger Nückel, Vera Rebmann, Jan Dürig, Ulrich Dührsen, Hans Grosse-Wilde

Blood (2005) 105 (4): 1694–1698.

https://doi.org/10.1182/blood-2004-08-3335

Published: 2005

Journal Articles

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

Silvia Deaglio, Andrea Capobianco, Luciana Bergui, Jan Dürig, Fortunato Morabito, Ulrich Dührsen, Fabio Malavasi

Blood (2003) 102 (6): 2146–2155.

https://doi.org/10.1182/blood-2003-03-0989

Published: 2003

Journal Articles

Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia

Jan Dürig, Holger Nückel, Andreas Hüttmann, Elisabeth Kruse, Tanja Hölter, Katja Halfmeyer, Anja Führer, Roland Rudolph, Naser Kalhori, Arnd Nusch, Silvia Deaglio, Fabio Malavasi, Tarik Möröy, Ludger Klein-Hitpass, Ulrich Dührsen

Blood (2003) 101 (7): 2748–2755.

https://doi.org/10.1182/blood-2002-09-2683

Published: 2003

Journal Articles

Expression of Macrophage Inflammatory Protein-1 Receptors in Human CD34 + Hematopoietic Cells and Their Modulation by Tumor Necrosis Factor- and Interferon-γ

Jan Dürig, Erika A. de Wynter, Christoph Kasper, Michael A. Cross, James Chang, Nydia G. Testa, Clare M. Heyworth

Blood (1998) 92 (9): 3073–3081.

https://doi.org/10.1182/blood.V92.9.3073

Published: 1998

Journal Articles

A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Chemotherapy

Mark J. Clemons, Ernest Marshall, Jan Dürig, Ken Watanabe, Anthony Howell, David Miles, Helena Earl, Julie Kiernan, Audrey Griffiths, K. Towlson, P. DeTakats, Nydia G. Testa, Mark Dougal, Michael G. Hunter, L. Michael Wood, Lloyd G. Czaplewski, Andrew Millar, T. Michael Dexter, Brian I. Lord

Blood (1998) 92 (5): 1532–1540.

https://doi.org/10.1182/blood.V92.5.1532

Published: 1998

NARROW

Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)

Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic Leukemia

Protein Kinase C-β Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo

Potent Anti-Leukemic Activity of a Novel Cdk9 Inhibitor in Preclinical CLL Mouse Models

Correlations Between Ofatumumab Exposure and Treatment Outcomes for Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Ofatumumab, Fludarabine, and Cyclophosphamide Chemoimmunotherapy

Expanded CLL CD8 + T-Cells Are Driven Into a Senescent KLRG1 + Effector Memory Phenotype

Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany

Polyclonal Free Light Chain Elevation and Mortality In the German Heinz Nixdorf Recall Study

Ofatumumab Combined with Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results From a Randomized, Multicenter, International, Two-Dose, Parallel Group, Phase II Trial.

Mir-34a as Part of the Chemotherapy Resistance Network in Chronic Lymphocytic Leukemia.

Gene Expression Signatures Separate B-Cell Chronic Lymphocytic Leukemia Prognostic Subgroups Defined by ZAP-70 and CD38 Expression Status.

The Gene Expression Profile of T-Cell Prolymphocytic Leukemia with inv(14)(q11q32) Reflects the Pattern of Chromosomal Imbalances.

Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia

Expression of Macrophage Inflammatory Protein-1 Receptors in Human CD34 + Hematopoietic Cells and Their Modulation by Tumor Necrosis Factor- and Interferon-γ

A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only